Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs

Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs

Topic:
  • Guidelines
  • Heart Failure

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs
No ratings

This content is not intended for UK or US Health Care Professionals

Overview

During this unique broadcast, "Next Steps in Heart Failure: Changing Paradigms in Therapy to Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. Radcliffe’s roundtable discussions are to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at forthcoming events via lively discussion and data presentations.

 

Dr Javed Butler (University of Mississippi Medical Center, Jackson, Mississippi, US) leads proceedings, and is joined by Dr Clyde Yancy (Northwestern University Feinberg School of Medicine, Illinois, US), Prof Faiez Zannad (University of Lorraine, Nancy, FR), and Prof Christiane Angermann (University Hospital of Würzburg, Würzburg, DE) for an insightful presentation and a discussion.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities. This programme is supported by an unrestricted educational grant from Boehringer Ingelheim.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session, ‘Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Support Statement

This programme is supported by an educational grant from the Boehringer Ingelheim ​and Lilly Alliance.

Instructions to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.

 

  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • Global Heart Failure Physicians
  • General Cardiologists

Learning Objectives

Upon participation in the roundtable discussion physicians will be able to:

  • Recall the utility of EF in heart failure treatment, patient selection and treatment response 
  • Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy 
  • Incorporate quality of life measures for assessing therapeutic efficacy in HF 
  • Recall outcomes from heart failure trials from recent congress and publications and their impact on practice 

Module

Title

Duration

Speakers

Session 1 How is the landscape of HF Changing? Javed Butler
Session 2 A Changing Paradigm in the Progression of HF Therapy Initiation Christiane Angermann
Session 2.2 Roundtable Discussion Javed Butler Christiane Angermann Clyde W Yancy Faiez Zannad
Session 3 An ESC 2022 Update: Relevant New Medical Data Faiez Zannad
Session 4 Applying the Guidelines in Clinical Practice Clyde W Yancy
Session 5 Roundtable Discussion: QOL, Implementation in Practice and Future Trials Javed Butler Clyde W Yancy Faiez Zannad Christiane Angermann
Session 1.

How is the landscape of HF Changing?

Duration:

Speakers: Javed Butler

Session 2.

A Changing Paradigm in the Progression of HF Therapy Initiation

Duration:

Speakers: Christiane Angermann

Session 2.2.
Session 3.

An ESC 2022 Update: Relevant New Medical Data

Duration:

Speakers: Faiez Zannad

Session 4.

Applying the Guidelines in Clinical Practice

Duration:

Speakers: Clyde W Yancy

Session 5.

Roundtable Discussion: QOL, Implementation in Practice and Future Trials

Duration:

Speakers: Javed Butler Clyde W Yancy Faiez Zannad Christiane Angermann

Speaker

Clyde W Yancy

Vice-Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine

Dr Clyde W Yancy, is Vice-Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine in Chicago, US. He concomitantly serves as Chief of Cardiology at Northwestern University, Feinberg School of Medicine, and Associate Director of the Bluhm Cardiovascular Institu

View full profile

Faiez Zannad

University of Lorraine, FR

Prof Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU)

View full profile

Christiane Angermann

University Hospital of Würzburg, Würzburg, Germany

Prof Christiane E. Angermann is trained in Medicine/Cardiology in Munich. At the Munich Univ. Hospital, she established a Multidisciplinary Program for Advanced Heart Failure (HF)/HTX.

View full profile

Chair

Javed Butler

Baylor Scott and White Research Institute, Dallas, US

Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US.

View full profile
1.00 EBAC

Related Courses

Translating Aortic Stenosis Guidelines Into Practice: Evidence-Based Decisions for the Heart Team
  • 1.00 EBAC

Learning objectives

  • Recall recent guideline recommendations for the management of aortic stenosis
  • Summarise the evidence supporting TAVI across the sub-groups of aortic stenosis, age and surgical risk
  • Develop an expert guided approach to patient selection and referral for TAVI
  • Adopt an evidence-based approach for the lifetime management of younger patients with aortic stenosis
See more
Revolutionising Thrombosis Treatment in ACS, SSP and AF
  • 1.00 EBAC

Learning objectives

  • Discuss the unmet needs in thrombosis management, MACE burden after ACS, stroke in AF and secondary stroke prevalence and consequences
  • Evaluate the current standard of care for the treatment of ACS, SSP and AF and its limitations
  • Review guidelines and critique current prescribing practices and the implications of inadequate treatment
  • Explain the different strategies for targeting FXI and how FXI inhibition mechanisms differentiate from traditional anticoagulation therapies
  • Identify emerging anticoagulant strategies and describe the efficacy and safety data from Phase 2 FXI inhibitor clinical trials as well as ongoing Phase 3 trials and potential place in therapy for ACS, AF and SSP
  • Apply evidence-based anticoagulation strategies by optimising treatment decisions and addressing patient-specific risk factors
See more
Managing Hypertension in CVD: How Low Can We Go?
  • 1.00 EBAC

Learning objectives

  • Describe the link between CVD and hypertension
  • Classify hypertension patients according to their cardiovascular risk
  • Recall recent guideline-directed and evidence-based strategies for managing very high CVD risk patients
  • Apply guideline-directed and evidence-based management strategies to a case study
  • Use expert guidance to adopt optimal multidisciplinary antihypertensive management strategies in patients with very high cardiovascular risk
See more
Advancing Patient Care in Hypertrophic Cardiomyopathy
  • 0.50 AMA PRA Credit

Learning objectives

  • Recall recent trial data for novel disease modifying therapy in HCM
  • Describe the evolving guideline directed approach to managing HCM
  • Develop an expert-led approach to implementing novel therapy in clinical practice
See more